3Stuart BL.Factors impacting on the problem of antibiotic resistance[J].J Antimicrob Chemother,2002,49:30-35.
4CunHa BA.Antibiotic resistance[J].Med Clin North Am,2000,84:1407-1429.
5Cunha BA.Effective antibiotic-resistance control strategies[J].Lancet,2001,357:1307-1309.
6Waterer GW,Somes GW,Wunderink RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Inter Med,2001,161:1837-1842.
7Niederman MS,Mandell LA,Anzueto A,et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis,assessment of severity,antimicrobial thereapy,and prevention. Am J Respir Crit Care Med,2001,163:1730-1754.
8Ichimiya T,Yamsaki T,Nasu M. In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation. J Antimicrob Chemother,1994,34:331-341.
9Holmes A,Ganner M,Guane MS,et al.Staphylococcus aureus isolate carrying panton-valentine leucocidin genes in England and wales:frequency,characterization,and association with clinical disease.Clin Microbiol,2005,43:2384.
10Fiebelkorn KR,Crawford SA,McElmeel ML,et al.Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase negative Staphylococci.Clin Microbiol,2003,4740-4744.
